The 5-2-1 Rule in Parkinson's: What the Numbers Mean

If you or someone you love has lived with Parkinson's for a few years, you may have heard a doctor mention "the 5-2-1 rule" or seen it in a support group. It is one of the simplest and most useful ideas in Parkinson's care: three numbers that help answer a hard question families quietly carry around. Is the disease advancing beyond what the current pill routine controls well?

Here is what each number means, where the rule comes from, and what to do if the numbers describe your day.

Want the quick version? Our free one-minute 5-2-1 self-check walks through the three questions in plain language and gives you a printable list of questions for your care team. Nothing you answer is stored.

The Three Numbers

• 5: taking levodopa five or more times a day. Every scheduled dose of any levodopa medicine counts, including rescue doses. Needing doses this often usually means each dose is wearing off faster than it used to.
• 2: two or more hours of off time a day. "Off" time is when the medication is not working well: movement gets slower, stiffer, or shakier until the next dose kicks in. Two hours can hide in plain sight as a slow morning plus a rough late afternoon.
• 1: one or more hours of dyskinesia a day. Dyskinesia is extra, involuntary movement (writhing, fidgeting, swaying) that is different from tremor. It often shows up when medication is at its peak.

The three numbers describe different faces of the same underlying issue: oral medication is no longer delivering smooth, predictable control across the whole day.

Where the Rule Comes From

The 5-2-1 criteria were proposed in 2018 by an international panel of movement disorder specialists (Antonini and colleagues) who wanted a screen simple enough that any clinician, patient, or family member could apply it without special equipment or scales. In the published research, meeting any one of the three criteria is the signal worth reviewing. You do not need all three.

Since then the rule has been used widely in clinics and studies to flag people whose Parkinson's may need more than a standard oral regimen, and who deserve a proper treatment review.

Why the Rule Matters

Off time and dyskinesia tend to creep in slowly, and families are remarkably good at adapting around them. Breakfast moves earlier. Errands get scheduled around the good hours. The rough patch after lunch becomes just how things are. Nobody names the pattern out loud, so nobody reviews the treatment.

The 5-2-1 rule turns that vague sense of "harder than it used to be" into a specific, answerable question for a care team. When the pattern is named, several good things can follow: the current regimen may be adjusted, a referral to a movement disorder specialist may be made, an evaluation for device-assisted therapies may begin, or a clinical trial may turn out to fit. None of those conversations start until someone notices the numbers.

What Meeting the Criteria Does Not Mean

Meeting the 5-2-1 criteria is not a diagnosis, and it does not mean the current treatment is wrong. It does not mean surgery or a device is needed. Plenty of people who meet a criterion do well for years with adjustments to their existing medicines. What it means is that an assessment is worth asking for, in these specific terms, at the next appointment.

How to Check Where You Stand

You could count doses and estimate hours on the back of an envelope, but off time and dyskinesia are easy to miss or mislabel, even for people who have lived with Parkinson's for years. Our free 5-2-1 self-check walks through the three questions one at a time, with plain-language help for the terms, and ends with a printable conversation guide: what to say, what to ask, and what to bring to the appointment. It takes about a minute, and nothing you answer is stored or sent anywhere.

What to Discuss With Your Care Team

Doctors know the 5-2-1 criteria, so naming them works. A simple opener: "I did a 5-2-1 check and my answers matched one of the criteria. I would like to talk about whether my current treatment plan is still the right fit." From there, useful questions include whether the off time or dyskinesia can be reduced by adjusting the current routine, at what point a referral for an advanced-therapy evaluation would make sense, and whether a movement disorder specialist should be involved if one is not already.

If the appointment feels rushed, ask for a follow-up visit dedicated to this conversation. Advancing symptoms are exactly what a care team wants to hear about early, because small adjustments are easier than big ones. Our guide on how to talk to your neurologist covers how to make the most of the visit.

What Comes After the Conversation

If a review confirms that oral medication alone is no longer enough, the options are better than they have ever been. Longer-acting levodopa formulations can smooth out the day; our comparison of carbidopa-levodopa formulations explains how they differ. Device-assisted therapies like deep brain stimulation and continuous infusion target exactly the fluctuations the 5-2-1 rule screens for; our plain comparison of DBS vs Duopa vs focused ultrasound walks through who each is for.

And research is active here too. Many recruiting trials specifically enroll people with motor fluctuations or dyskinesia. Browse recruiting trials for advanced Parkinson's, or find trials that match your situation in 60 seconds.

This article is educational, not medical advice. Never change any medication based on a rule of thumb; the 5-2-1 criteria are a reason to start a conversation, not a treatment decision.

Ready to see where you stand? Take the one-minute 5-2-1 self-check and bring the printable guide to your next appointment.